Abstract
Background
Dementia is one of the most disabling conditions associated with old age. With increasing life expectancy, prevalence of both dementia and diabetes is rising. The complex pathological relationship between diabetes mellitus (DM) and dementia has been studied, but is not yet fully understood.
Aims
The main objective of this study was to investigate the relationship between metabolic parameters and the cognitive function in older diabetics.
Methods
A total number of 360 diabetic subjects, age 65 years and over, and 300 older people controls were included. Clinical and biological parameters, together with the cognitive function, were assessed every 6 months over a 18-month period, for each study participant.
Results
By employing a multivariate linear regression analysis, several significant relationships have been identified: between Clock Drawing Test (CDT) scores and HbA1c (R 2 = 0.68); between CDT scores (R 2 = 0.51) and overall MMSE scores (R 2 = 0.43) on one hand, and DM duration in years, on the other hand; also between CDT scores and BMI (R 2 = 0.59). There was no significant association between fasting serum glucose (FSG), total serum cholesterol, LDL cholesterol or triglycerides levels and cognitive function scores (p > 0.05).
Conclusions
The close detailed monitoring of the cognitive function and a rigorous metabolic control are important, especially in the very early stages of DM. Addressing factors such as weight control in older diabetic patients could contribute to better cognitive outcomes.
Similar content being viewed by others
References
Prince M, Jackson J (eds) (2009) World Alzheimer report. Alzheimer’s Disease International, London
Alzheimer Europe (2013) Dementia in Europe: Yearbook 2013: national policies covering the care and support of people with dementia and their carers: including the Alzheimer Europe Annual Report 2012
Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diab Res Clin Prac 7:4–14
Prince M, Albanese E, Guerchet M et al (2014) World Alzheimer Report. Alzheimer’s Disease International, London
Barbagallo M, Dominguez LJ (2014) Type 2 diabetes mellitus and Alzheimer’s disease. World J Diabetes 5:889–893
Wong TY, Klein R, Sharrett AR (2002) Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the atherosclerosis risk in communities study. Stroke 33:1487–1492
van Harten B, de Leeuw F-E, Weinstein HC et al (2006) Brain imaging in patients with diabetes. A systematic review. Diabetes Care 29:2539–2548
Tiehuis AM, van der Graaf Y, Visseren FL (2008) Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease. Stroke 39:1600–1603
Biessels GJ, Kappelle LJ (2005) Increased risk of Alzheimer’s disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 33:1041–1044
Williamson R, McNeilly A, Sutherland C (2012) Insulin resistance in the brain: an old-age or new-age problem? Biochem Pharmacol 84:737–745
Tong M, de la Monte SM (2009) Ceramide-mediated neurodegeneration: relevance to Diabetes-associated neurodegeneration. J Alzheimers Dis 16:705–714
Gasparini L, Xu H (2003) Potential roles of insulin and IGF-1 in Alzheimer’s disease. Trends Neurosci 26:404–407
Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625
Kodl CT, Seaquist ER (2008) Cognitive dysfunction and diabetes mellitus. Endocr Rev 29:494–511
Cardoso S, Correia SC, Santos RX et al (2013) Hyperglycaemia, hypoglycaemia and dementia: role of mitochondria and uncoupling proteins. Curr Mol Med 13:586–601
Zhao B, Pan BS, Shen SW et al (2013) Diabetes-induced central neuritic dystrophy and cognitive deficits are associated with the formation of oligomeric reticulon-3 via oxidative stress. J Biol Chem 288:15590–15599
Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state—a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 12:189–198
Pinto E, Peters R (2009) Literature review of the clock drawing test as a tool for cognitive screening. Dement Geriatr Cogn Disord 27:201–213
Sunderland T, Hill JL, Mellow AM et al (1989) Clock drawing in Alzheimer’s disease: a novel measure of dementia severity. J Am Geriatr Soc 37:725–729
Juby A, Tench S, Baker V (2002) The value of clock drawing in identifying executive cognitive dysfunction in people with a normal mini-mental state examination score. CMAJ 167:859–864
Carlson MC, Xue QL, Zhou J et al (2009) Executive decline and dysfunction precedes declines in memory: the Women’s Health and Aging Study II. J Gerontol A Biol Sci Med Sci 64:110–117
Nishtala A, Preis SR, Beiser A et al (2014) Midlife cardiovascular risk impacts executive function: Framingham offspring study. Alzheimer Dis Assoc Disord 28:16–22
Arvanitakis Z, Wilson RS, Li Y et al (2006) Diabetes and function in different cognitive systems in older individuals without dementia. Diabetes Care 29:560–565
Alencar RC, Cobas RA, Gomes MB (2010) Assessment of cognitive status in patients with type 2 diabetes through the mini-mental status examination: a cross-sectional study. Diabetol Metab Syndr 2:10
Cukierman-Yaffe T, Gerstein H, Williamson J et al (2009) Relationship between baseline glycaemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care 32:221–226
Cukierman-Yaffe T, Gerstein HC, Anderson C et al (2009) Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND Research Programme. Diabetes Res Clin Pract 83:387–393
Tolppanen AM, Lavikainen P, Solomon A et al (2013) History of medically treated diabetes and risk of Alzheimer disease in a nationwide case-control study. Diabetes Care 36:2015–2019
Whitmer RA, Sidney S, Selby J et al (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64:277–281
Ronnemaa E, Zethelius B, Lannfelt L et al (2011) Vascular risk factors and dementia: 40-year follow-up of a population-based cohort. Dement Geriatr Cogn Disord 31:460–466
Ancelin ML, Ripoche E, Dupuy AM et al (2013) Sex differences in the associations between lipid levels and incident dementia. J Alzheimers Dis 34:519–528
Notkola IL, Sulkava R, Pekkanen J et al (1998) Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer’s disease. Neuroepidemiology 17:14–20
Stewart R, White LR, Xue QL et al (2007) Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia aging study. Arch Neurol 64:103–107
Tan ZS, Seshadri S, Beiser A et al (2003) Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham study. Arch Intern Med 163:1053–1057
Mielke MM, Zandi PP, Shao H et al (2010) The 32-year relationship between cholesterol and dementia from midlife to late life. Neurology 75:1888–1895
Beydoun MA, Beason-Held LL, Kitner-Triolo MH et al (2011) Statins and serum cholesterol’s associations with incident dementia and mild cognitive impairment. J Epidemiol Community Health 65:949–957
Solomon A, Kareholt I, Ngandu T et al (2007) Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology 68:751–756
Gorospe EC, Dave JK (2007) The risk of dementia with increased body mass index. Age Ageing 36:23–29
Beydoun MA, Beydoun HA, Wang Y (2008) Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev 9:204–218
Anstey KJ, Cherbuin N, Budge M et al (2011) Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev 12:e426–e437
Gustafson DR, Backman K, Waern M et al (2009) Adiposity indicators and dementia over 32 years in Sweden. Neurology 73:1559–1566
Stewart R, Masaki K, Xue QL et al (2005) A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia aging study. Arch Neurol 62:55–60
Whitmer RA, Gustafson DR, Barrett-Connor E et al (2008) Central obesity and increased risk of dementia more than three decades later. Neurology 71:1057–1064
Luchsinger JA, Cheng D, Tang MX et al (2012) Central obesity in the elderly is related to late-onset Alzheimer disease. Alzheimer Dis Assoc Disord 26:101–105
Acknowledgments
The authors would like to express their deepest gratitude to Professor Alan Walker (BA, DLitt, Hon. D.Soc.Sc. (HKBU), FBA, FRSA, AcSS, CBE), Professor of Social Policy and Social Gerontology at the University of Sheffield, UK, for his continuous and invaluable guidance and support. Moreover, the authors wish to extend their acknowledgement to Professor Mihail Coculescu, MD, PhD, FRCP, Professor of Endocrinology at the University of Pharmacy and Medicine “Carol Davila”, Bucharest, Romania, Member of Romanian Academy, for his enthusiastic encouragement and constructive suggestions.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Statement of human and animal rights
All procedures performed in the present study that involved human participants were in accordance with the ethical standards of our institution and our National Research Committee and also with the 1964 Helsinki declaration and its later amendments and comparable ethical standards, including the respect for human rights.
Informed consent
Informed consent was obtained from all individual participants prior to their inclusion in the study, after a careful explanation of the details of the procedures.
Funding
This study was funded by Ministry of Education—Executive Unit for Financing Education, Higher Research, Development and Innovation (EUFEHGDI), Romania (Grant Number 1FL/2008). The corresponding author received financial support through the project entitled “CERO—Career profile: Romanian Researcher”, grant number POSDRU/159/1.5/S/135760/2014, financed by Ministry of Regional Development and Public Administration—University of Medicine and Pharmacy “Carol Davila”, Romania.
Rights and permissions
About this article
Cite this article
Herghelegiu, A.M., Nacu, R.M. & Prada, G.I. Metabolic parameters and cognitive function in a cohort of older diabetic patients. Aging Clin Exp Res 28, 1105–1112 (2016). https://doi.org/10.1007/s40520-015-0515-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-015-0515-0